- Home
- RMR vs ALDX Comparison
RMR vs ALDX Comparison
Compare RMR & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMR
- ALDX
- Stock Information
- Founded
- RMR 1986
- ALDX 2004
- Country
- RMR United States
- ALDX United States
- Employees
- RMR N/A
- ALDX N/A
- Industry
- RMR Professional Services
- ALDX Biotechnology: Pharmaceutical Preparations
- Sector
- RMR Consumer Discretionary
- ALDX Health Care
- Exchange
- RMR Nasdaq
- ALDX Nasdaq
- Market Cap
- RMR 306.9M
- ALDX 304.9M
- IPO Year
- RMR N/A
- ALDX 2014
- Fundamental
- Price
- RMR $17.25
- ALDX $6.91
- Analyst Decision
- RMR Buy
- ALDX Strong Buy
- Analyst Count
- RMR 2
- ALDX 2
- Target Price
- RMR $32.00
- ALDX $10.00
- AVG Volume (30 Days)
- RMR 179.8K
- ALDX 607.7K
- Earning Date
- RMR 05-06-2025
- ALDX 05-01-2025
- Dividend Yield
- RMR 10.47%
- ALDX N/A
- EPS Growth
- RMR N/A
- ALDX N/A
- EPS
- RMR 0.97
- ALDX N/A
- Revenue
- RMR $199,940,000.00
- ALDX N/A
- Revenue This Year
- RMR $371.91
- ALDX N/A
- Revenue Next Year
- RMR $1.02
- ALDX N/A
- P/E Ratio
- RMR $17.34
- ALDX N/A
- Revenue Growth
- RMR N/A
- ALDX N/A
- 52 Week Low
- RMR $16.89
- ALDX $2.71
- 52 Week High
- RMR $26.43
- ALDX $7.20
- Technical
- Relative Strength Index (RSI)
- RMR 34.11
- ALDX 61.80
- Support Level
- RMR $17.97
- ALDX $6.79
- Resistance Level
- RMR $19.06
- ALDX $7.20
- Average True Range (ATR)
- RMR 0.44
- ALDX 0.56
- MACD
- RMR -0.07
- ALDX 0.03
- Stochastic Oscillator
- RMR 16.63
- ALDX 88.02
About RMR The RMR Group Inc.
The RMR Group Inc is a holding company that conducts its business through its subsidiary, which is an alternative asset management company that invests in real estate and manages real estate-related businesses. Its business consists of providing management services to publicly owned real estate investment trusts, or REITs, and real estate-related operating companies. It also provides management services to real estate securities mutual funds and commercial real estate finance companies. The company's operating segment is RMR LLC and All Other Operations. The RMR Group derives its revenue from providing business and property management services as well as advisory and other services.
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.